A combination of major histocompatibility complex (MHC) I overexpression and type I interferon induce mitochondrial dysfunction in human skeletal myoblasts.
Anastasia Thoma, Razan AlomoshiD, Holly L. Bond, Tania Akter‐Miah, Nasser Al‐ShantiiD, Hans DegensiD, Vanja Pekovic‐VaughaniD, Adam P. LightfootiD
Abstract
The overexpression of major histocompatibility complex (MHC) I on the surface of muscle fibres is a characteristic hallmark of the idiopathic inflammatory myopathies (IIMs), collectively termed myositis. Alongside MHC-I overexpression, sub-types of myositis, display a distinct type I interferon (IFN) signature. This study examined the combinational effects of elevated MHC-I and type I IFNs (IFN/{beta}) on mitochondrial function, as mitochondrial dysfunction is often seen in IIMs. Human skeletal muscle myoblasts were transfected with an MHC-I isoform using the mammalian HLA-A2/Kb vector. Mitochondrial respiration, mitochondrial membrane potential, and reactive oxygen/nitrogen species generation were assessed with or without IFN and IFN{beta}. We show that MHC-I overexpression in human skeletal muscle myoblasts led to decreased basal glycolysis and mitochondrial respiration, cellular spare respiratory capacity, ATP-linked respiration, and an increased proton leak, which were all exaggerated by type I IFNs. Mitochondrial membrane depolarisation was induced by MHC-I overexpression both in absence and presence of type I IFNs. Human myoblasts overexpressing MHC-I showed elevated nitric oxide generation that was abolished when combined with IFN. MHC-I on its own did not result in an increased ROS production, but IFN on their own, or combined with MHC-I overexpression did induce elevated ROS generation. We present new evidence that MHC-I overexpression and type I IFNs aggravate the effects each has on mitochondrial function in human skeletal muscle cells, providing novel insights into their mechanisms of action and suggesting important implications in the further study of myositis pathogenesis.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 9
- FWCI
- 2.30
- Field percentile
- top 13%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Major Histocompatibility Complex (MHC) I-induced Endoplasmic Reticulum (ER) Stress mediates the secretion of pro-inflammatory muscle-derived cytokines
A. Thoma, K. E. Earl, … A. P. Lightfoot·bioRxiv·Jun 29, 2022
- Interferon-gamma mediates skeletal muscle lesions through JAK/STAT pathway activation in inclusion body myositis
C. Hou, B. Periou, … F. J. Authier·bioRxiv·Dec 16, 2021
- Mitochondrial instability contributes to IFN-driven heart disease.
Arati Naveen Kumar, Amelia Meecham, … Caroline Anne Jefferies·bioRxiv·Sep 15, 2025
- Spatial transcriptomic analysis of muscle biopsy from treatment-naive juvenile dermatomyositis patients reveals mitochondrial abnormalities despite disease-related interferon driven signature
Aris E Syntakas, Melissa Kartawinata, … Meredyth Grace Llewellyn Wilkinson·Annals of the Rheumatic DiseasesPeer-reviewed·Aug 9, 2025
- Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor-induced myositis
I. Pinal-Fernandez, A. Quintana, … A. L. Mammen·bioRxiv·Dec 12, 2022
- Mitochondrial leakage and mtDNA damage trigger early immune response in Inclusion Body Myositis.
Felix Kleefeld, Emily Cross, … Rita Horváth·bioRxiv·Aug 5, 2024